University of North Carolina - Chapel Hill Endowment Fund

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Employees: -

Market Cap: -

Website

Clinical Trials

Human Cytochrome P450 4F Enzymes and Drug Interactions

Phase 1

Completed

Conditions: Healthy Volunteers
Drug Drug Interactions

Interventions: Drug: Warfarin
Drug: Lovastatin
Drug: Placebo

First Posted Date: 2010-11-30

Last Posted Date: 2013-01-21

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 19

Registration Number: NCT01250535

Locations: 🇺🇸
University of North Carolina, Clinical and Translational Research Center (CTRC), Chapel Hill, North Carolina, United States

Heart to Health: A Combined Lifestyle and Medication Intervention to Reduce Cardiovascular Disease (CVD) Risk

Not Applicable

Completed

Conditions: Cardiovascular Disease
Coronary Heart Disease

Interventions: Behavioral: Lifestyle and medication intervention

First Posted Date: 2010-11-22

Last Posted Date: 2013-02-06

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 489

Registration Number: NCT01245686

Locations: 🇺🇸
Durham Family Practice, Durham, North Carolina, United States
🇺🇸
Dayspring Family Medicine, Eden, North Carolina, United States
🇺🇸
Cabarrus Family Medicine Residency, Kannapolis, North Carolina, United States

and more 2 locations

Decision Support Interventions (DESI) for Prostate Cancer Screening and Treatment - Study 2

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Behavioral: Prostate cancer treatment DESI

First Posted Date: 2010-11-19

Last Posted Date: 2014-12-23

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 218

Registration Number: NCT01244568

Locations: 🇺🇸
University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States
🇺🇸
Palo Alto Medical Foundation Research Institute, Palo Alto, California, United States

Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability

Not Applicable

Terminated

Conditions: Cystic Fibrosis
Pulmonary Fibrosis
Alpha-1 Antitrypsin Deficiency
Sarcoidosis
Emphysema
Chronic Obstructive Pulmonary Disease (COPD)
Bronchiectasis
Pulmonary Hypertension

Interventions: Other: Conventional Lung Transplant
Device: Steen Solution™

First Posted Date: 2010-11-16

Last Posted Date: 2018-07-13

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 11

Registration Number: NCT01241942

Locations: 🇺🇸
UNC Hospitals, Chapel Hill, North Carolina, United States

Decision Support Interventions (DESI) for Prostate Cancer Screening - Study 1

Not Applicable

Completed

Conditions: Healthy Men Age 50 Who Are Considering PSA Screening

Interventions: Behavioral: DESI for viewing at Shared Medical Appointment
Behavioral: DESI for home viewing
Behavioral: Option of SMA and DESI or DESI only

First Posted Date: 2010-11-16

Last Posted Date: 2013-06-25

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 2521

Registration Number: NCT01241656

Locations: 🇺🇸
Palo Alto Medical Foundation Research Institute, Palo Alto, California, United States
🇺🇸
University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States

Atypical Antipsychotic Treatment Effect On Brain Function In Schizophrenia Measured By FMRI

Not Applicable

Completed

Conditions: Schizophrenia

Interventions: Drug: Olanzapine
Drug: Risperidone

First Posted Date: 2010-11-04

Last Posted Date: 2015-04-03

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 34

Registration Number: NCT01234454

Locations: 🇺🇸
Unc Psychiatry, Chapel Hill, North Carolina, United States

We Can Prevent Diabetes: A Behavioral Intervention to Reduce Diabetes Risk in African Americans

Phase 1

Completed

Conditions: Prediabetes

Interventions: Behavioral: Mindfulness-based diabetes prevention education group
Behavioral: Conventional diabetes prevention education group

First Posted Date: 2010-10-25

Last Posted Date: 2012-06-15

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 74

Registration Number: NCT01227473

Locations: 🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Non-virologic Methods to Diagnose Treatment Eligibility in HIV-exposed Infants

Completed

Conditions: HIV Infections

First Posted Date: 2010-10-18

Last Posted Date: 2014-09-18

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 1126

Registration Number: NCT01222130

Locations: 🇿🇲
George Health Centre, Lusaka, Zambia
🇿🇲
Matero Reference Health Centre, Lusaka, Zambia
🇿🇲
Kamwala Health Centre, Lusaka, Zambia

Differences in Evoked Intracellular Interferon Signaling Pathways Using Single Cell Phosphoprotein Profiling

Phase 1

Completed

Conditions: Hepatitis C

Interventions: Drug: Interferon Alfa-2b

First Posted Date: 2010-10-08

Last Posted Date: 2016-11-15

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 22

Registration Number: NCT01217359

Locations: 🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

Oxytocin Treatment of Alcohol Withdrawal

Phase 1

Completed

Conditions: Alcohol Withdrawal

Interventions: Drug: intranasal oxytocin spray
Other: intranasal spray without oxytocin

First Posted Date: 2010-09-30

Last Posted Date: 2014-05-13

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 14

Registration Number: NCT01212185

Locations: 🇺🇸
University of North Carolina Hospitals, Chapel Hill, North Carolina, United States
🇺🇸
Central Regional Hospital, Raleigh, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy